HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 207 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,008,595 | +284.8% | 26,403 | +473.2% | 0.00% | +300.0% |
| Q4 2022 | $262,082 | +52.4% | 4,606 | +18.0% | 0.00% | 0.0% |
| Q2 2022 | $172,000 | +27.4% | 3,902 | +15.6% | 0.00% | 0.0% |
| Q1 2022 | $135,000 | +3.1% | 3,374 | +3.9% | 0.00% | 0.0% |
| Q4 2021 | $131,000 | +11.0% | 3,247 | +12.0% | 0.00% | 0.0% |
| Q3 2021 | $118,000 | +0.9% | 2,898 | +12.1% | 0.00% | 0.0% |
| Q2 2021 | $117,000 | +8.3% | 2,585 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $108,000 | +30.1% | 2,588 | +32.4% | 0.00% | 0.0% |
| Q4 2020 | $83,000 | +84.4% | 1,955 | +15.0% | 0.00% | 0.0% |
| Q3 2020 | $45,000 | -4.3% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $47,000 | +80.8% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $26,000 | -10.3% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $29,000 | +7.4% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $27,000 | +8.0% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $25,000 | -19.4% | 1,700 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $31,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |